![]() Cumberland Pharmaceuticals Cumberland Pharmaceuticals is a company that focuses on the development and commercialization of prescription products for the hospital acute care and gastroenterology sectors. | ![]() UCB UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions. | |
Founding Date | Founding Date 1999 | Founding Date 1928 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Nashville, US HQ | Locations Brussels, BE HQ Melbourne, AU Vienna, AT Braine L'alleud, BE Braine L'alleud, BE Leuven, BE São Paulo, BR see more |
Employees | Employees 91 | Employees 9,052 |
Valuation ($) | Valuation ($) 17.6 m | Valuation ($) 34.3 b |
Financial | ||
Revenue (est.) | Revenue (est.) $44.5m (FY, 2025) | Revenue (est.) €7.4b (FY, 2025) |
Cost of goods | Cost of goods $6.7m (FY, 2025) | Cost of goods €1.4b (FY, 2025) |
Gross profit | Gross profit $37.9m (FY, 2025) | Gross profit €7.2b (FY, 2025) |
Net income | Net income ($2.9m) (FY, 2025) | Net income €1.6b (FY, 2025) |

UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.
View company